Susanto, Johana M., Colvin, Emily K., Biankin, Andrew V., Scarlett, Christopher J., Pinese, Mark, Chang, David K., Pajic, Marina, Mawson, Amanda, Caldon, C. Elizabeth, Musgrove, Elizabeth A., Henshall, Susan M., Sutherland, Robert L.. Spandidos Publications; 2015. The epigenetic agents suberoylanilide hydroxamic acid and 5-AZA-2' deoxycytidine decrease cell proliferation, induce cell death and delay the growth of MiaPaCa2 pancreatic cancer cells in vivo.

Dreyer, Stephan B., Pinese, Mark, Jamieson, Nigel B., Scarlett, Christopher J., Colvin, Emily K., Pajic, Marina, Johns, Amber L., Humphris, Jeremy L., Wu, Jianmin, Cowley, Mark J., Chou, Angela, Nagrial, Adnan M., Chantrill, Lorraine, Chin, Venessa T., Jones, Marc D., Moran-Jones, Kim, Carter, Christopher Ross, Dickson, Euan J., Samra, Jaswinder S., Merrett, Neil D., Gill, Anthony J., Kench, JG, Duthie, F, Miller, DK, Cooke, S, Aust, D, Knösel, T, Rümmele, P, Grützmann, R, Pilarsky, C, Nguyen, NQ, Musgrove, EA, Bailey, PJ, McKay, CJ, Biankin, AV, Chang, DK, Australian Pancreatic Cancer Genome Initiative, Glasgow Precision Oncology Laboratory. Lippincott Williams & Wilkins; 2020. Precision oncology in surgery: patient selection for operable pancreatic cancer.

Chang, David K., Jamieson, Nigel B., Nagrial, Adnan M., Chantrill, Lorraine A., Chin, Venessa T., Pinho, Andreia V., Rooman, Ilse, Cowley, Mark J., Wu, Jianmin, Mead, R. Scott, Colvin, Emily K., Samra, Jaswinder S., Johns, Amber L., Corbo, Vincenzo, Bassi, Claudio, Falconi, Massimo, Lawlor, Rita T., Crippa, Stefano, Sperandio, Nicola, Bersani, Samantha, Dickson, Euan J., Mohamed, Mohamed A. A., Oien, Karin A., Scarlett, Christopher J., Foulis, Alan K., Musgrove, Elizabeth A., Sutherland, Robert L., Kench, James G., Carter, C. Ross, Gill, Anthony J., Scarpa, Aldo, McKay, Colin J., Biankin, Andrew V., Pajic, Marina, Chou, Angela, Pinese, Mark, Humphris, Jeremy L., Jones, Marc D., Toon, Christopher. American Society of Clinical Oncology; 2013. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of Vater.

Humphris, Jeremy L., Johns, Amber L., Mead, R. Scott, Gill, Anthony J., Samra, Jaswinder S., Kench, James G., Musgrove, Elizabeth A., Tucker, Katherine M., Spigelman, Allan D., Waddell, Nic, Grimmond, Sean M., Biankin, Andrew V. Biankin, Simpson, Skye H., Australian Pancreatic Cancer Genome Initiative,, Cowley, Mark J., Pajic, Marina, Chang, David K., Nagrial, Adnan M., Chin, Venessa T., Chantrill, Lorraine A., Pinese, Mark. Wiley-Blackwell Publishing; 2014. Clinical and pathologic features of familial pancreatic cancer.

Waddell, Nicola, Pajic, Marina, Quinn, Michael C. J., Robertson, Alan J., Fadlullah, Muhammad Z. H., Bruxner, Tim J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Patch, Ann-Marie, Scarlett, Christopher J., , , , , , , , , , Chang, David K., , , , , , , , , , , Kassahn, Karin S., , , , , , , , , , , Bailey, Peter, , , , , , , , , , , Johns, Amber L., , , , , , , , , , , Miller, David, , , , , , , , , , , Nones, Katia, , , , , , , , , , , Quek, Kelly. Nature Publishing Group; 2015. Whole genomes redefine the mutational landscape of pancreatic cancer.

Humphris, Jeremy L., Patch, Ann-Marie, Quinn, Michael C. J., Bruxner, Timothy J. C., Christ, Angelika N., Harliwong, Ivon, Idrisoglu, Senel, Manning, Suzanne, Nourse, Craig, Nourbakhsh, Ehsan, Stone, Andrew, Wilson, Peter J., Nones, Katia, Scarlett, Christopher J., , , , , , , , , , Bailey, Peter J., , , , , , , , , , , Johns, Amber L., , , , , , , , , , , McKay, Skye, , , , , , , , , , , Chang, David K., , , , , , , , , , , Miller, David K., , , , , , , , , , , Pajic, Marina, , , , , , Kassahn, Karin S.. W. B. Saunders; 2017. Hypermutation in pancreatic cancer.